(Q46820304)

25 December 2017

title

Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum (English)

1 reference

25 December 2017

author name string

Minshall RD

1

1 reference

25 December 2017

Nedumgottil SJ

2

1 reference

25 December 2017

Igić R

3

1 reference

25 December 2017

Erdös EG

4

1 reference

25 December 2017

Rabito SF

5

1 reference

25 December 2017

publication date

1 August 2000

1 reference

25 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Peptides

1 reference

25 December 2017

volume

21

1 reference

25 December 2017

issue

8

1 reference

25 December 2017

page(s)

1257-1264

1 reference

25 December 2017

ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Measurement of urinary kallikrein activity by kinin radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Naturally occurring active N-domain of human angiotensin I-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Potentiation of Bradykinin Actions by ACE Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Instrument for recording isotonic contractions of smooth muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

An enzyme in human blood plasma that inactivates bradykinin and kallidins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Effects of bradykinin and angiotensin on smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Enhancement of bradykinin and resensitization of its B2 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Effects of the N-terminal sequence of ACE on the properties of its C-domain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Angiotensin I-converting enzyme inhibitors potentiate bradykinin's inotropic effects independently of blocking its inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Soluble dextran complexes of Kallikrein, Bradykinin and enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

From peptides to peptidases: a chronicle of drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Metabolism of substance P and bradykinin by human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

The bradykinin potentiating activity of two pentapeptides on various isolated smooth muscle preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

The mechanism of action of two bradykinin-potentiating peptides on isolated smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Kallikrein, kallidin, kallikrein inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

Second Kininase in Human Blood Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900267-9

7 January 2021

10.1016/S0196-9781(00)00267-9

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

11035213

1 reference

25 December 2017